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Background
Dyslipidaemia in HIV has been linked with both a
cytokine-driven lipid metabolism re-arrangement in sig-
nificant viraemia, and with the use of highly-active
antiretroviral therapy (HAART), especially protease inhib-
itors (PIs) and non-nucleoside reverse transcriptase inhib-
itors (NNRTIs).
Methods
This study was a retrospective review, evaluating the effi-
cacy and safety of Ezetimibe in our cohort of HIV-positive
patients stable on HAART with dyslipidaemia. Out of the
29 such individuals prescribed 10 mg Ezetimibe once
daily, 17 received it in addition to a statin, and 12 received
it as a direct replacement for a statin.
Summary of results
Prior to initiation of Ezetimibe, median serum total cho-
lesterol and triglyceride levels were 6.3 mmol/l (range:
3.6–10.7) and 2.9 mmol/l (range: 0.54–13.02), respec-
tively. Review of the lipid profiles of the cohort after 12
weeks of Ezetimibe therapy revealed (see data in Figure 1).
Two individuals discontinued Ezetimibe prematurely.
Conclusion
These results suggest that Ezetimibe may have an impor-
tant role as an effective therapy for HAART-induced dysli-
pidaemia.
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